CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-26 | LYONS GARY A Director | Grant or award | +25,000 | 75,000 | ||
| 2023-05-26 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-26 | LAPOINTE ANTHONY GREGG Director | Grant or award | +25,000 | 75,000 | ||
| 2023-05-26 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-26 | MOOS WALTER H Director | Grant or award | +25,000 | 77,222 | ||
| 2023-05-26 | MOOS WALTER H Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-26 | Ali-Jackson Kamil Director | Grant or award | +25,000 | 43,750 | ||
| 2023-05-26 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-26 | Kotzin Brian L. Director | Grant or award | +25,000 | 75,000 | ||
| 2023-05-26 | Kotzin Brian L. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-26 | HANNAH ALISON L. Director | Grant or award | +25,000 | 56,250 | ||
| 2023-05-26 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-02-06 | RODRIGUEZ RAUL R CEO, President | Sale | −20,340 | $1.75 | $36K | 1,680,713 |
| 2023-02-02 | Santos David A EVP, Chief Commercial Officer | Sale | −5,388 | $1.66 | $9K | 144,612 |
| 2023-01-26 | RODRIGUEZ RAUL R CEO, President | Grant or award | +300,000 | 1,701,053 | ||
| 2023-01-26 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 |
Page 9 of 9 · 176 trades